BioLife Solutions, Inc. (BLFS) news stock charts
BioLife Solutions, Inc. (BLFS/BLFS.OB) Investment Summary:
BioLife Solutions, Inc. engages in the development, manufacture, and marketing of proprietary hypothermic storage and cryopreservation solutions for cells, tissues, and organs. Its proprietary HypoThermosol and CryoStor solutions are marketed to companies, laboratories, and academic institutions involved in research and commercial clinical applications. The company’s line of serum-free and protein-free preservation solutions are formulated to reduce preservation-induced, delayed-onset cell damage, and death. Its HypoThermosol series of products include HypoThermosol FRS to decrease the free radical accumulation in cells undergoing hypothermic preservation; and HypoThermosol Purge, an acellul...BIOLIFE SOLUTIONS INC (BLFS:OTC Bulletin Board Market)
Snapshot of BIOLIFE SOLUTIONS INC (BLFS)
|
OPEN
$0.10
|
PREVIOUS CLOSE
$0.10
|
|
|
DAY HIGH
$0.10
|
DAY LOW
$0.10
|
|
|
52 WEEK HIGH
09/15/09 - $0.25
|
52 WEEK LOW
03/31/09 - $0.05
|
|
|
MARKET CAP
7.0M
|
AVERAGE VOLUME 10 D
8.9K
|
|
|
EPS TTM
$-0.04
|
SHARES OUTSTANDING
69.6M
|
|
|
BLFS Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for BIOLIFE SOLUTIONS INC (BLFS)
BioLife Solutions, Inc. and OriGen Biomedical Inc. announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosolR cell and tissue storage/transport media and CryoStorT cryopreservation media. BioLife and OriGen have entered into a non-exclusive, worldwide distribution agreement under which OriGen will purchase BioLife's HypoThermosol and CryoStor products for distribution to OriGen customers. In addition, the parties executed a contract manufacturing services agreement under which BioLife will manufacture OriGen's DMSO and DMSO/Dextran cryopreservation media products under sterile GMP conditions into various packaging options.
BioLife Solutions, Inc. announced that on December 16, 2009, the company entered into an Amendment to its Secured Convertible Multi-Draw Term Loan Facility Agreement with each of Thomas Girschweiler, a director and stockholder of the company, and Walter Villiger, an affiliate of the company, each a non-U.S. Person pursuant to which (a) the term of the Secured Convertible Multi-Draw Term Loan Note was extended to January 11, 2011, and (b) the conversion feature of the Note was eliminated. The Note previously delivered to each of the Investors also was amended to reflect the changes to the Facility Agreement.
BioLife Solutions, Inc. announced that it has executed a license and custom cGMP manufacturing agreement with Centocor Research & Development, Inc. The agreement includes the production of a custom variant of BioLife's proprietary serum-free and protein-free CryoStor biopreservation media product, which is formulated with a reduced concentration of 2% DMSO.
BioLife Solutions, Inc. financial resources
BLFS Competitors
| Company | Last | Change |
| Life Technologies Corp | $53.33 USD | -0.22 |
| Lonza Group AG | SFr.86.00 CHF | +0.30 |
| Sigma-Aldrich Corp | $54.71 USD | -0.16 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | BLFS | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 4.6x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
BLFS |
||
BLFS transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About BioLife Solutions, Inc.
BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement
Read article
BioLife Solutions Granted Japanese Biopreservation Patent
Read article
BioLife Solutions and OriGen Biomedical to Offer Sterile, Pre-Filled Biologic Cell and Tissue Packaging Products to the Cell Therapy and Regenerative Medicine Markets
Read article
BioLife Solutions Achieves ISO 13485 Quality Management Systems Certification
Read article
BioLife Solutions and OriGen Biomedical to Offer Sterile, Pre-Filled Biologic Cell and Tissue Packaging Products to the Cell Therapy and Regenerative Medicine Markets
Read article
BioLife Solutions Achieves ISO 13485 Quality Management Systems Certification
Read article
BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement
Read article
BioLife Solutions Announces HypoThermosol(R) and CryoStor(TM) Distribution Agreement With Sigma-Aldrich
Read article
BioLife Solutions Granted Japanese Biopreservation Patent
Read article